BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wang Y, Shang W, Niu M, Tian J, Xu K. Hypoxia-active nanoparticles used in tumor theranostic. Int J Nanomedicine 2019;14:3705-22. [PMID: 31190820 DOI: 10.2147/IJN.S196959] [Cited by in Crossref: 21] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhou ZH, Liang SY, Zhao TC, Chen XZ, Cao XK, Qi M, Huang YY, Ju WT, Yang M, Zhu DW, Pang YC, Zhong LP. Overcoming chemotherapy resistance using pH-sensitive hollow MnO2 nanoshells that target the hypoxic tumor microenvironment of metastasized oral squamous cell carcinoma. J Nanobiotechnology 2021;19:157. [PMID: 34039370 DOI: 10.1186/s12951-021-00901-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Xavierselvan M, Divecha HR, Hajra M, Silwal S, Macwan I. Towards Tumor Targeting via Invasive Assay Using Magnetospirillum magneticum. Front Microbiol 2021;12:697132. [PMID: 34367097 DOI: 10.3389/fmicb.2021.697132] [Reference Citation Analysis]
3 Siddique S, Chow JCL. Application of Nanomaterials in Biomedical Imaging and Cancer Therapy. Nanomaterials (Basel) 2020;10:E1700. [PMID: 32872399 DOI: 10.3390/nano10091700] [Cited by in Crossref: 46] [Cited by in F6Publishing: 32] [Article Influence: 23.0] [Reference Citation Analysis]
4 Lee S, Kim Y, Lee ES. Hypoxia-Responsive Azobenzene-Linked Hyaluronate Dot Particles for Photodynamic Tumor Therapy. Pharmaceutics 2022;14:928. [DOI: 10.3390/pharmaceutics14050928] [Reference Citation Analysis]
5 Le TN, Lin CJ, Shen YC, Lin KY, Lee CK, Huang CC, Rao NV. Hyaluronic Acid Derived Hypoxia-Sensitive Nanocarrier for Tumor Targeted Drug Delivery. ACS Appl Bio Mater 2021;4:8325-32. [PMID: 35005953 DOI: 10.1021/acsabm.1c00847] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
6 Chen H, Cheng H, Wu W, Li D, Mao J, Chu C, Liu G. The blooming intersection of transcatheter hepatic artery chemoembolization and nanomedicine. Chinese Chemical Letters 2020;31:1375-81. [DOI: 10.1016/j.cclet.2020.03.024] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
7 Li Y, Chen Z, Gu L, Duan Z, Pan D, Xu Z, Gong Q, Li Y, Zhu H, Luo K. Anticancer nanomedicines harnessing tumor microenvironmental components. Expert Opin Drug Deliv 2022. [PMID: 35244503 DOI: 10.1080/17425247.2022.2050211] [Reference Citation Analysis]
8 Chen Y, Yang J, Fu S, Wu J. Gold Nanoparticles as Radiosensitizers in Cancer Radiotherapy. Int J Nanomedicine 2020;15:9407-30. [PMID: 33262595 DOI: 10.2147/IJN.S272902] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
9 Ferrari D, Gessi S, Merighi S, Nigro M, Travagli A, Burns JS. Potentiating Cancer Immune Therapy via Nanomaterials and Purinergic Signaling. Front Cell Dev Biol 2022;10:893709. [DOI: 10.3389/fcell.2022.893709] [Reference Citation Analysis]
10 Pierce KM, Miklavcic WR, Cook KP, Hennen MS, Bayles KW, Hollingsworth MA, Brooks AE, Pullan JE, Dailey KM. The Evolution and Future of Targeted Cancer Therapy: From Nanoparticles, Oncolytic Viruses, and Oncolytic Bacteria to the Treatment of Solid Tumors. Nanomaterials (Basel) 2021;11:3018. [PMID: 34835785 DOI: 10.3390/nano11113018] [Reference Citation Analysis]
11 Dou L, Meng X, Yang H, Dong H. Advances in technology and applications of nanoimmunotherapy for cancer. Biomark Res 2021;9:63. [PMID: 34419164 DOI: 10.1186/s40364-021-00321-9] [Reference Citation Analysis]
12 Xin F, Wu M, Cai Z, Zhang X, Wei Z, Liu X, Liu J. Tumor Microenvironment Triggered Cascade-Activation Nanoplatform for Synergistic and Precise Treatment of Hepatocellular Carcinoma. Adv Healthc Mater 2021;10:e2002036. [PMID: 33644987 DOI: 10.1002/adhm.202002036] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
13 Xu Y, Chen P, Tang L, Zhang X, Shi F, Ning X, Bi J, Qu Y, Liu H. Hypoxia responsive and tumor-targeted mixed micelles for enhanced cancer therapy and real-time imaging. Colloids Surf B Biointerfaces 2022;215:112526. [PMID: 35512561 DOI: 10.1016/j.colsurfb.2022.112526] [Reference Citation Analysis]
14 Li J, Burgess DJ. Nanomedicine-based drug delivery towards tumor biological and immunological microenvironment. Acta Pharm Sin B 2020;10:2110-24. [PMID: 33304781 DOI: 10.1016/j.apsb.2020.05.008] [Cited by in Crossref: 47] [Cited by in F6Publishing: 40] [Article Influence: 23.5] [Reference Citation Analysis]
15 Yang Z, Deng W, Zhang X, An Y, Liu Y, Yao H, Zhang Z. Opportunities and Challenges of Nanoparticles in Digestive Tumours as Anti-Angiogenic Therapies. Front Oncol 2021;11:789330. [PMID: 35083147 DOI: 10.3389/fonc.2021.789330] [Reference Citation Analysis]